JAMES BROWN: Open Payments
NPI 1134190077 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 53 payments from 17 companies in 2025. Trend: 2023 $494 · 2024 $533 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $126 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Astellas Pharma US Inc | 4 | $88 |
| PFIZER INC. | 5 | $87 |
| Medtronic, Inc. | 3 | $61 |
| Amgen Inc. | 4 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Exact Sciences Corporation | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
Products named: LEQVIO, Veozah, JARDIANCE, MOUNJARO, ELIQUIS, INTELLIS ADAPTIVESTIM, VOQUEZNA, REXULTI.
Industry payments across SC — which companies pay providers there.
